Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "PTA Balloon Catheters - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.
"PTA Balloon Catheters-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the PTA Balloon Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
PTA Balloon Catheters segment includes Standard Balloon Catheters and PTA Peripheral DEB Catheters. A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. Standard Balloon Catheters are used to open up the arteries that are blocked by plaque build-up (atherosclerosis).
Scope
- Extensive coverage of the PTA Balloon Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of PTA Balloon Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of PTA Balloon Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
2 Introduction
2.1 PTA Balloon Catheters Overview
3 Products under Development
3.1 PTA Balloon Catheters-Pipeline Products by Stage of Development
3.2 PTA Balloon Catheters-Pipeline Products by Segment
3.3 PTA Balloon Catheters-Pipeline Products by Territory
3.4 PTA Balloon Catheters-Pipeline Products by Regulatory Path
3.5 PTA Balloon Catheters-Pipeline Products by Estimated Approval Date
3.6 PTA Balloon Catheters-Ongoing Clinical Trials
4 PTA Balloon Catheters-Pipeline Products under Development by Companies
4.1 PTA Balloon Catheters Companies-Pipeline Products by Stage of Development
4.2 PTA Balloon Catheters-Pipeline Products by Stage of Development
5 PTA Balloon Catheters Companies and Product Overview
6 PTA Balloon Catheters-Recent Developments
7 Appendix
Companies Mentioned
- Andramed GmbH
- AnGes Inc
- AngioCure, Inc.
- Boston Scientific Corp
- Cagent Vascular LLC
- Cardiovascular Systems Inc
- Concept Medical Inc
- Contego Medical LLC
- Endocor GmbH
- eucatech AG
- Genesis MedTech International Pvt Ltd
- Hexacath SA
- Lifetech Scientific (Shenzhen) Co Ltd
- Lutonix Inc
- M.A. Med Alliance SA
- Medtronic Plc
- Micell Technologies Inc
- MicroPort Endovascular (Shanghai) Co., Ltd.
- NuVascular Technologies Inc
- Orchestra BioMed Inc
- QT Vascular Ltd
- QualiMed Innovative Medizinprodukte GmbH
- SiL Vascular Ltd
- Spectranetics Corp
- SurModics Inc
- Tailored Medical Devices Inc
- Transit Scientific LLC
- TransMed7 LLC
- Vascular Nanotransfer Technologies
- Zhejiang Zylox Medical Device Co Ltd
For more information about this report visit https://www.researchandmarkets.com/r/8h5ajg
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.